Evaluation of the Innovance D-DIMER analytical performance
Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Be...
Ausführliche Beschreibung
Autor*in: |
Coen Herak, Desiree [verfasserIn] Milos, Marija [verfasserIn] Zadro, Renata [verfasserIn] |
---|
Format: |
E-Artikel |
---|
Erschienen: |
Walter de Gruyter ; 2009 |
---|
Schlagwörter: |
---|
Umfang: |
7 |
---|
Reproduktion: |
Walter de Gruyter Online Zeitschriften |
---|---|
Übergeordnetes Werk: |
Enthalten in: Clinical chemistry and laboratory medicine - Berlin [u.a.] : De Gruyter, 1998, 47(2009), 8 vom: 24. Juni, Seite 945-951 |
Übergeordnetes Werk: |
volume:47 ; year:2009 ; number:8 ; day:24 ; month:06 ; pages:945-951 ; extent:7 |
Links: |
---|
DOI / URN: |
10.1515/CCLM.2009.219 |
---|
Katalog-ID: |
NLEJ246727624 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLEJ246727624 | ||
003 | DE-627 | ||
005 | 20230506145544.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220814s2009 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1515/CCLM.2009.219 |2 doi | |
028 | 5 | 2 | |a artikel_Grundlieferung.pp |
035 | |a (DE-627)NLEJ246727624 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
100 | 1 | |a Coen Herak, Desiree |e verfasserin |4 aut | |
245 | 1 | 0 | |a Evaluation of the Innovance D-DIMER analytical performance |
264 | 1 | |b Walter de Gruyter |c 2009 | |
300 | |a 7 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51. | ||
533 | |f Walter de Gruyter Online Zeitschriften | ||
650 | 4 | |a coagulation | |
650 | 4 | |a D-dimer | |
650 | 4 | |a evaluation | |
650 | 4 | |a particle-enhanced immunoturbidimetric assay | |
700 | 1 | |a Milos, Marija |e verfasserin |4 aut | |
700 | 1 | |a Zadro, Renata |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d Berlin [u.a.] : De Gruyter, 1998 |g 47(2009), 8 vom: 24. Juni, Seite 945-951 |w (DE-627)NLEJ248235222 |w (DE-600)1492732-9 |x 1437-4331 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2009 |g number:8 |g day:24 |g month:06 |g pages:945-951 |g extent:7 |
856 | 4 | 0 | |u https://doi.org/10.1515/CCLM.2009.219 |z Deutschlandweit zugänglich |
912 | |a GBV_USEFLAG_U | ||
912 | |a ZDB-1-DGR | ||
912 | |a GBV_NL_ARTICLE | ||
951 | |a AR | ||
952 | |d 47 |j 2009 |e 8 |b 24 |c 06 |h 945-951 |g 7 |
author_variant |
h d c hd hdc m m mm r z rz |
---|---|
matchkey_str |
article:14374331:2009----::vlainfhinvnedmrnlt |
hierarchy_sort_str |
2009 |
publishDate |
2009 |
allfields |
10.1515/CCLM.2009.219 doi artikel_Grundlieferung.pp (DE-627)NLEJ246727624 DE-627 ger DE-627 rakwb Coen Herak, Desiree verfasserin aut Evaluation of the Innovance D-DIMER analytical performance Walter de Gruyter 2009 7 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51. Walter de Gruyter Online Zeitschriften coagulation D-dimer evaluation particle-enhanced immunoturbidimetric assay Milos, Marija verfasserin aut Zadro, Renata verfasserin aut Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 47(2009), 8 vom: 24. Juni, Seite 945-951 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:47 year:2009 number:8 day:24 month:06 pages:945-951 extent:7 https://doi.org/10.1515/CCLM.2009.219 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 47 2009 8 24 06 945-951 7 |
spelling |
10.1515/CCLM.2009.219 doi artikel_Grundlieferung.pp (DE-627)NLEJ246727624 DE-627 ger DE-627 rakwb Coen Herak, Desiree verfasserin aut Evaluation of the Innovance D-DIMER analytical performance Walter de Gruyter 2009 7 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51. Walter de Gruyter Online Zeitschriften coagulation D-dimer evaluation particle-enhanced immunoturbidimetric assay Milos, Marija verfasserin aut Zadro, Renata verfasserin aut Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 47(2009), 8 vom: 24. Juni, Seite 945-951 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:47 year:2009 number:8 day:24 month:06 pages:945-951 extent:7 https://doi.org/10.1515/CCLM.2009.219 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 47 2009 8 24 06 945-951 7 |
allfields_unstemmed |
10.1515/CCLM.2009.219 doi artikel_Grundlieferung.pp (DE-627)NLEJ246727624 DE-627 ger DE-627 rakwb Coen Herak, Desiree verfasserin aut Evaluation of the Innovance D-DIMER analytical performance Walter de Gruyter 2009 7 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51. Walter de Gruyter Online Zeitschriften coagulation D-dimer evaluation particle-enhanced immunoturbidimetric assay Milos, Marija verfasserin aut Zadro, Renata verfasserin aut Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 47(2009), 8 vom: 24. Juni, Seite 945-951 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:47 year:2009 number:8 day:24 month:06 pages:945-951 extent:7 https://doi.org/10.1515/CCLM.2009.219 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 47 2009 8 24 06 945-951 7 |
allfieldsGer |
10.1515/CCLM.2009.219 doi artikel_Grundlieferung.pp (DE-627)NLEJ246727624 DE-627 ger DE-627 rakwb Coen Herak, Desiree verfasserin aut Evaluation of the Innovance D-DIMER analytical performance Walter de Gruyter 2009 7 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51. Walter de Gruyter Online Zeitschriften coagulation D-dimer evaluation particle-enhanced immunoturbidimetric assay Milos, Marija verfasserin aut Zadro, Renata verfasserin aut Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 47(2009), 8 vom: 24. Juni, Seite 945-951 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:47 year:2009 number:8 day:24 month:06 pages:945-951 extent:7 https://doi.org/10.1515/CCLM.2009.219 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 47 2009 8 24 06 945-951 7 |
allfieldsSound |
10.1515/CCLM.2009.219 doi artikel_Grundlieferung.pp (DE-627)NLEJ246727624 DE-627 ger DE-627 rakwb Coen Herak, Desiree verfasserin aut Evaluation of the Innovance D-DIMER analytical performance Walter de Gruyter 2009 7 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51. Walter de Gruyter Online Zeitschriften coagulation D-dimer evaluation particle-enhanced immunoturbidimetric assay Milos, Marija verfasserin aut Zadro, Renata verfasserin aut Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 47(2009), 8 vom: 24. Juni, Seite 945-951 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:47 year:2009 number:8 day:24 month:06 pages:945-951 extent:7 https://doi.org/10.1515/CCLM.2009.219 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 47 2009 8 24 06 945-951 7 |
source |
Enthalten in Clinical chemistry and laboratory medicine 47(2009), 8 vom: 24. Juni, Seite 945-951 volume:47 year:2009 number:8 day:24 month:06 pages:945-951 extent:7 |
sourceStr |
Enthalten in Clinical chemistry and laboratory medicine 47(2009), 8 vom: 24. Juni, Seite 945-951 volume:47 year:2009 number:8 day:24 month:06 pages:945-951 extent:7 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
coagulation D-dimer evaluation particle-enhanced immunoturbidimetric assay |
isfreeaccess_bool |
false |
container_title |
Clinical chemistry and laboratory medicine |
authorswithroles_txt_mv |
Coen Herak, Desiree @@aut@@ Milos, Marija @@aut@@ Zadro, Renata @@aut@@ |
publishDateDaySort_date |
2009-06-24T00:00:00Z |
hierarchy_top_id |
NLEJ248235222 |
id |
NLEJ246727624 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ246727624</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506145544.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220814s2009 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/CCLM.2009.219</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">artikel_Grundlieferung.pp</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ246727624</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Coen Herak, Desiree</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evaluation of the Innovance D-DIMER analytical performance</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">Walter de Gruyter</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Walter de Gruyter Online Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">coagulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">D-dimer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">particle-enhanced immunoturbidimetric assay</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Milos, Marija</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zadro, Renata</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Clinical chemistry and laboratory medicine</subfield><subfield code="d">Berlin [u.a.] : De Gruyter, 1998</subfield><subfield code="g">47(2009), 8 vom: 24. Juni, Seite 945-951</subfield><subfield code="w">(DE-627)NLEJ248235222</subfield><subfield code="w">(DE-600)1492732-9</subfield><subfield code="x">1437-4331</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:47</subfield><subfield code="g">year:2009</subfield><subfield code="g">number:8</subfield><subfield code="g">day:24</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:945-951</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/CCLM.2009.219</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DGR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">47</subfield><subfield code="j">2009</subfield><subfield code="e">8</subfield><subfield code="b">24</subfield><subfield code="c">06</subfield><subfield code="h">945-951</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
series2 |
Walter de Gruyter Online Zeitschriften |
author |
Coen Herak, Desiree |
spellingShingle |
Coen Herak, Desiree misc coagulation misc D-dimer misc evaluation misc particle-enhanced immunoturbidimetric assay Evaluation of the Innovance D-DIMER analytical performance |
authorStr |
Coen Herak, Desiree |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ248235222 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut |
collection |
NL |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
1437-4331 |
topic_title |
Evaluation of the Innovance D-DIMER analytical performance coagulation D-dimer evaluation particle-enhanced immunoturbidimetric assay |
publisher |
Walter de Gruyter |
publisherStr |
Walter de Gruyter |
topic |
misc coagulation misc D-dimer misc evaluation misc particle-enhanced immunoturbidimetric assay |
topic_unstemmed |
misc coagulation misc D-dimer misc evaluation misc particle-enhanced immunoturbidimetric assay |
topic_browse |
misc coagulation misc D-dimer misc evaluation misc particle-enhanced immunoturbidimetric assay |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Clinical chemistry and laboratory medicine |
hierarchy_parent_id |
NLEJ248235222 |
hierarchy_top_title |
Clinical chemistry and laboratory medicine |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)NLEJ248235222 (DE-600)1492732-9 |
title |
Evaluation of the Innovance D-DIMER analytical performance |
ctrlnum |
(DE-627)NLEJ246727624 |
title_full |
Evaluation of the Innovance D-DIMER analytical performance |
author_sort |
Coen Herak, Desiree |
journal |
Clinical chemistry and laboratory medicine |
journalStr |
Clinical chemistry and laboratory medicine |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
2009 |
contenttype_str_mv |
txt |
container_start_page |
945 |
author_browse |
Coen Herak, Desiree Milos, Marija Zadro, Renata |
container_volume |
47 |
physical |
7 |
format_se |
Elektronische Aufsätze |
author-letter |
Coen Herak, Desiree |
doi_str_mv |
10.1515/CCLM.2009.219 |
author2-role |
verfasserin |
title_sort |
evaluation of the innovance d-dimer analytical performance |
title_auth |
Evaluation of the Innovance D-DIMER analytical performance |
abstract |
Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51. |
abstractGer |
Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51. |
abstract_unstemmed |
Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51. |
collection_details |
GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE |
container_issue |
8 |
title_short |
Evaluation of the Innovance D-DIMER analytical performance |
url |
https://doi.org/10.1515/CCLM.2009.219 |
remote_bool |
true |
author2 |
Milos, Marija Zadro, Renata |
author2Str |
Milos, Marija Zadro, Renata |
ppnlink |
NLEJ248235222 |
mediatype_str_mv |
c |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.1515/CCLM.2009.219 |
up_date |
2024-07-06T09:12:12.641Z |
_version_ |
1803820343118266368 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ246727624</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506145544.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220814s2009 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/CCLM.2009.219</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">artikel_Grundlieferung.pp</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ246727624</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Coen Herak, Desiree</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evaluation of the Innovance D-DIMER analytical performance</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">Walter de Gruyter</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. Methods: We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. Results: Within-run coefficients of variation (CVs) for samples with low, borderline, slightly, and extremely increased D-dimer concentrations were 2.1%–5.5%, whereas between-run CVs for control samples with low and extremely increased D-dimer were 5.5%–8.4%. The assay exhibited good linearity in the working range between 0.17 mg/L and 5.45 mg/L fibrinogen equivalent units (FEU), with the lower limit of detection of 0.099 mg/L FEU. The upper reference value determined in 40 plasma samples from healthy volunteers was 0.495 mg/L FEU. The results obtained in 457 fresh plasma samples were compared with results obtained with VIDAS D-Dimer Exclusion. Passing and Bablok regression analysis demonstrated highly significant correlation (y=1.370x–0.108, r=0.952, p<0.001). Bland and Altman difference plots demonstrated slightly higher results obtained with Innovance D-DIMER that was more pronounced with increasing values. Very good agreement between both assays was observed (κ=0.860; 95% confidence interval (CI), 0.811–0.908). Conclusions: This study demonstrates that Innovance D-DIMER fulfills all analytical requirements for daily routine use. Clin Chem Lab Med 2009;47:945–51.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Walter de Gruyter Online Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">coagulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">D-dimer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">particle-enhanced immunoturbidimetric assay</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Milos, Marija</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zadro, Renata</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Clinical chemistry and laboratory medicine</subfield><subfield code="d">Berlin [u.a.] : De Gruyter, 1998</subfield><subfield code="g">47(2009), 8 vom: 24. Juni, Seite 945-951</subfield><subfield code="w">(DE-627)NLEJ248235222</subfield><subfield code="w">(DE-600)1492732-9</subfield><subfield code="x">1437-4331</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:47</subfield><subfield code="g">year:2009</subfield><subfield code="g">number:8</subfield><subfield code="g">day:24</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:945-951</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/CCLM.2009.219</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DGR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">47</subfield><subfield code="j">2009</subfield><subfield code="e">8</subfield><subfield code="b">24</subfield><subfield code="c">06</subfield><subfield code="h">945-951</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
score |
7.400509 |